Abiopharma

AGENTIX CORP. (AGTX)

Symbol	AGTX
Name	AGENTIX CORP.
Sector	UNDEFINED
Region	North America
Industry	-
Address	92629 United States CA 32932 Pacific Coast Highway #14-254
Telephone	(949) 933-5411
Fax	—
Email	—
Website	http://www.agentixcorp.com
Incorporation	US
Incorporated On	2013
Employees	—
Fiscal Year	3/31
Public Since	—
Exchanges	OTC;NASDAQ
Auditor	Fruci & Associates II, PLLC;
Audit Status	AUDITED
Reporting Status	U.S. Reporting: SEC Reporting
CIK	0001603345
Description	(OTC:AGTX), is a clinical-stage biotechnology company that is pursuing the development of a comprehensive suite of novel, science-driven, biopharmaceuticals that target the endocannabinoid system across multiple therapeutic areas with greater market exclusivity, for the treatment of metabolic diseases; including Type 2 Diabetes Mellitus, Chronic Obesity, Non-alcoholic Fatty Liver Disease (NAFLD), and Non-alcoholic Steatohepatitis (NASH). AGENTIX acquired specific assets and licensing rights, including licensing rights associated with intellectual property as part of Worldwide Exclusive Agreements with NHRI (National Heath Research Institute) and RTI (Research Triangle Institute) International. Additional info from OTC: (OTC:AGTX), is a clinical-stage biotechnology company that is pursuing the development of a comprehensive suite of novel, science-driven, biopharmaceuticals that target the endocannabinoid system across multiple therapeutic areas with greater market exclusivity, for the treatment of metabolic diseases; including Type 2 Diabetes Mellitus, Chronic Obesity, Non-alcoholic Fatty Liver Disease (NAFLD), and Non-alcoholic Steatohepatitis (NASH). AGENTIX acquired specific assets and licensing rights, including licensing rights associated with intellectual property as part of Worldwide Exclusive Agreements with NHRI (National Heath Research Institute) and RTI (Research Triangle Institute) International.

2026-02-17 18:26

Agentix Corp. (AGTX) Files Form 10-Q

2025-08-22 00:00

(61% Neutral) AGENTIX CORP. (AGTX) Reports Net Loss for 2025-06-30

2025-08-15 20:59

New Form NT 10-Q - Agentix Corp. Filed: 2025-08-15 AccNo: 0001477932-25-005988 Size: 20 KB

2025-02-18 00:00

(42% Neutral) AGENTIX CORP. (AGTX) Reports Profit for 2024-12-31

2025-02-14 20:59

New Form NT 10-Q - Agentix Corp. Filed: 2025-02-14 AccNo: 0001477932-25-001033 Size: 24 KB

2024-11-18 00:00

(42% Neutral) AGENTIX CORP. (AGTX) Reports Net Loss for 2024-09-30

2024-11-14 17:25

New Form NT 10-Q - Agentix Corp. Filed: 2024-11-14 AccNo: 0001477932-24-007174 Size: 25 KB

2024-08-30 20:14

New Form 10-K - Agentix Corp. Filed: 2024-08-30 AccNo: 0001477932-24-005401 Size: 2 MB

2024-08-27 11:39

Pink Limited symbol attribute type Security_Name was changed. Previous value: -. New value: AGENTIX CORP.

2024-08-27 08:16

OTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: AGENTIX CORP.